Patents by Inventor Paul Pentel

Paul Pentel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230089068
    Abstract: Described are novel nicotine-binding antibodies and methods of using them for treating nicotine addiction and/or facilitating smoking cessation, or for treating nicotine overdose or nicotine poisoning.
    Type: Application
    Filed: August 12, 2022
    Publication date: March 23, 2023
    Applicants: ANTIDOTE THERAPEUTICS, INC., BliNK BIOMEDICAL, Hennepin Healthcare Research Institute
    Inventors: Matthew W. KALNIK, Thomas THISTED, Nicola BELTRAMINELLI, Stéphanie FALLOT, Zuzana BIESOVA, Steve FULLER, Mark G. LeSAGE, Paul PENTEL
  • Patent number: 11440970
    Abstract: Described are novel nicotine-binding antibodies and methods of using them for treating nicotine addiction and/or facilitating smoking cessation, or for treating nicotine overdose or nicotine poisoning.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: September 13, 2022
    Assignees: ANTIDOTE THERAPEUTICS, INC., BliNK BIOMEDICAL, Hennepin Healthcare Research Institute
    Inventors: Matthew W. Kalnik, Thomas Thisted, Nicola Beltraminelli, Stéphanie Fallot, Zuzana Biesova, Steve Fuller, Mark G. Lesage, Paul Pentel
  • Publication number: 20200377616
    Abstract: Described are novel nicotine-binding antibodies and methods of using them for treating nicotine addiction and/or facilitating smoking cessation, or for treating nicotine overdose or nicotine poisoning.
    Type: Application
    Filed: August 14, 2018
    Publication date: December 3, 2020
    Applicants: ANTIDOTE THERAPEUTICS, INC., BliNK BIOMEDICAL, Hennepin Healthcare Research Institute
    Inventors: Matthew W. KALNIK, Thomas THISTED, Nicola BELTRAMINELLI, Stéphanie FALLOT, Zuzana BIESOVA, Steve FULLER, Mark G. LESAGE, Paul PENTEL
  • Publication number: 20160375131
    Abstract: Provided herein are methods for rational design of nicotine haptens. More particularly, provided herein are methods for designing, selecting, and synthesizing nicotine haptens and nicotine hapten conjugates. Also provided herein are novel nicotine haptens and methods for using nicotine haptens to treat nicotine addiction.
    Type: Application
    Filed: June 22, 2016
    Publication date: December 29, 2016
    Inventors: Yung Chang, Sidney Hecht, Joseph Leal, Viswanath Arutla, Xiaowei Liu, Sriram Sokalingam, Paul Pentel
  • Publication number: 20150017201
    Abstract: The present invention provides DNA-nanostructures comprising and at least one targeting moiety, wherein the at least one targeting moiety is linked to the DNA-nanostructure; and wherein the at least one targeting moiety is nicotine or a nicotine analogue. These compounds elicit an immunogenic response in individuals and are useful as vaccines for ameliorating nicotine dependence.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 15, 2015
    Inventors: Yung Chang, Hao Yan, Sidney Hecht, Paul Pentel, Xiaowei Liu, Rumit Maini